Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May;51(5):e13554.
doi: 10.1111/eci.13554. Epub 2021 Apr 9.

Reconciling estimates of global spread and infection fatality rates of COVID-19: An overview of systematic evaluations

John P A Ioannidis  1
Affiliations
Review

Reconciling estimates of global spread and infection fatality rates of COVID-19: An overview of systematic evaluations

John P A Ioannidis. Eur J Clin Invest. 2021 May.

Abstract

Background: Estimates of community spread and infection fatality rate (IFR) of COVID-19 have varied across studies. Efforts to synthesize the evidence reach seemingly discrepant conclusions.

Methods: Systematic evaluations of seroprevalence studies that had no restrictions based on country and which estimated either total number of people infected and/or aggregate IFRs were identified. Information was extracted and compared on eligibility criteria, searches, amount of evidence included, corrections/adjustments of seroprevalence and death counts, quantitative syntheses and handling of heterogeneity, main estimates and global representativeness.

Results: Six systematic evaluations were eligible. Each combined data from 10 to 338 studies (9-50 countries), because of different eligibility criteria. Two evaluations had some overt flaws in data, violations of stated eligibility criteria and biased eligibility criteria (eg excluding studies with few deaths) that consistently inflated IFR estimates. Perusal of quantitative synthesis methods also exhibited several challenges and biases. Global representativeness was low with 78%-100% of the evidence coming from Europe or the Americas; the two most problematic evaluations considered only one study from other continents. Allowing for these caveats, four evaluations largely agreed in their main final estimates for global spread of the pandemic and the other two evaluations would also agree after correcting overt flaws and biases.

Conclusions: All systematic evaluations of seroprevalence data converge that SARS-CoV-2 infection is widely spread globally. Acknowledging residual uncertainties, the available evidence suggests average global IFR of ~0.15% and ~1.5-2.0 billion infections by February 2021 with substantial differences in IFR and in infection spread across continents, countries and locations.

Keywords: COVID-19; bias; global health; infection fatality rate; meta-analysis; seroprevalence.

PubMed Disclaimer

Conflict of interest statement

None.

I am the author of one of the six evaluations assessed in this article.

Figures

FIGURE 1
FIGURE 1
Flow diagram
See this image and copyright information in PMC

References

    1. Meyerowitz‐Katz G, Merone L. A systematic review and meta‐analysis of published research data on COVID‐19 infection fatality rates. Int J Infect Dis. 2020;101:138‐148. - PMC - PubMed
    1. Rostami A, Sepidarkish M, Leeflang MMG, et al. SARS‐CoV‐2 seroprevalence worldwide: a systematic review and meta‐analysis. Clin Microbiol Infect. 2021;27(3):331‐340. 10.1016/j.cmi.2020.10.020 - DOI - PMC - PubMed
    1. Bobrovitz N, Arora RK, Cao C, et al. Global seroprevalence of SARS‐CoV‐2 antibodies: a systematic review and meta‐analysis. medRxiv. 2020. 10.1101/2020.11.17.20233460 - DOI - PMC - PubMed
    1. Imperial College COVID‐19 response team . Report 34: COVID‐19 Infection Fatality Ratio: Estimates from Seroprevalence. October 29, 2020.
    1. Ioannidis JPA. The infection fatality rate of COVID‐19 inferred from seroprevalence data. Bull World Health Organ. 2021;99:19‐33F. - PMC - PubMed